@article{oai:nagasaki-u.repo.nii.ac.jp:00016673,
 author = {Matsuse, Hiroto and Nakata, Hiroko and Fukahori, Susumu and Tsuchida, Tomoko and Kawano, Tetsuya and Tomari, Shinya and Fukushima, Chizu and Matsuo, Nobuko and Asai, Sadahiro and Kohno, Shigeru},
 issue = {12},
 journal = {Internal Medicine},
 month = {Jul},
 note = {Objective: The present study aims to overcome problems associated with the early diagnosis of allergic bronchopulmonary mycosis (ABPM) using the current criteria. Patients and Methods: Clinical features including radiographic findings from 10 patients with definitive ABPM based on the diagnostic criteria of Rosenberg-Patterson were compared with those from 9 patients with ABPM clinically diagnosed by respiratory allergy specialists. Results: ABPM should be considered in patients with peripheral blood eosinophilia and pulmonary infiltration and/or central bronchiectasis when serum total IgE is elevated. Complication by bronchial asthma suggested ABPM, but was not essential. The expectoration of sputum containing solid components was a critical factor in patients with a history in ABPM. Evaluation of sputum cultures, serum specific IgE antibodies, skin tests and precipitating antibodies were required to establish a diagnosis, but the positive rate of these tests remained low. Conclusions: Even when a definitive diagnosis cannot be established, systemic corticosteroid therapy should be initiated for clinically diagnosed ABPM to prevent irreversible pulmonary dysfunction., Internal Medicine, vol.45(12), pp.759-762; 2006},
 pages = {759--762},
 title = {A Clinical Evaluation of Definitive and Clinical Allergic Bronchopulmonary Mycosis},
 volume = {45},
 year = {2006}
}